Logo image of CNTM

CONNECTM TECHNOLOGY SOLUTION (CNTM) Stock Fundamental Analysis

NASDAQ:CNTM - US2079441091 - Common Stock

0.4401 USD
-0.21 (-32.29%)
Last: 5/7/2025, 8:00:00 PM
0.259 USD
-0.18 (-41.15%)
After Hours: 5/7/2025, 8:00:00 PM
Fundamental Rating

1

Taking everything into account, CNTM scores 1 out of 10 in our fundamental rating. CNTM was compared to 93 industry peers in the Electrical Equipment industry. Both the profitability and financial health of CNTM have multiple concerns. CNTM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CNTM had negative earnings in the past year.
In the past year CNTM has reported a negative cash flow from operations.
CNTM Yearly Net Income VS EBIT VS OCF VS FCFCNTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -5M -10M

1.2 Ratios

CNTM has a Return On Assets (-21.73%) which is comparable to the rest of the industry.
CNTM has a Return On Equity (-44.61%) which is in line with its industry peers.
Industry RankSector Rank
ROA -21.73%
ROE -44.61%
ROIC N/A
ROA(3y)-9.67%
ROA(5y)N/A
ROE(3y)-78.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNTM Yearly ROA, ROE, ROICCNTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CNTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNTM Yearly Profit, Operating, Gross MarginsCNTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

CNTM has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for CNTM is higher compared to a year ago.
CNTM Yearly Shares OutstandingCNTM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 500K 1M 1.5M 2M
CNTM Yearly Total Debt VS Total AssetsCNTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

CNTM has an Altman-Z score of -0.79. This is a bad value and indicates that CNTM is not financially healthy and even has some risk of bankruptcy.
CNTM has a Altman-Z score (-0.79) which is in line with its industry peers.
A Debt/Equity ratio of 0.04 indicates that CNTM is not too dependend on debt financing.
The Debt to Equity ratio of CNTM (0.04) is better than 73.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -0.79
ROIC/WACCN/A
WACCN/A
CNTM Yearly LT Debt VS Equity VS FCFCNTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.02 indicates that CNTM may have some problems paying its short term obligations.
CNTM's Current ratio of 0.02 is on the low side compared to the rest of the industry. CNTM is outperformed by 95.83% of its industry peers.
A Quick Ratio of 0.02 indicates that CNTM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.02, CNTM is doing worse than 95.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
CNTM Yearly Current Assets VS Current LiabilitesCNTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

CNTM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.14%.
EPS 1Y (TTM)-92.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNTM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTM Price Earnings VS Forward Price EarningsCNTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNTM Per share dataCNTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CNTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONNECTM TECHNOLOGY SOLUTION

NASDAQ:CNTM (5/7/2025, 8:00:00 PM)

After market: 0.259 -0.18 (-41.15%)

0.4401

-0.21 (-32.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.48%
Inst Owner Change-79.42%
Ins Owners3.83%
Ins Owner Change0%
Market Cap15.63M
AnalystsN/A
Price Target3.32 (654.37%)
Short Float %0.43%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS1.1
TBVpS1.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.73%
ROE -44.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.67%
ROA(5y)N/A
ROE(3y)-78.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -0.79
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-294.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-294.55%
OCF growth 3YN/A
OCF growth 5YN/A